四环生物：2025年度业绩不达标，公司股票或终止上市

Core Viewpoint - The company is facing a delisting risk warning starting from April 30, 2025, due to potential conditions outlined in the stock listing rules, which could lead to termination of its stock listing after the 2025 annual report is disclosed [1] Financial Performance - The company has announced an earnings forecast for 2025, expecting a non-recurring net profit of between -46 million yuan and -33 million yuan, with operating revenue projected to be between 330 million yuan and 350 million yuan, which is unaudited [1] - The company will provide risk warnings every ten trading days until the annual report is disclosed [1]